glp-1 receptor agonist and dpp-4 inhibitor combination not recommended combining with guideline GLP-1 receptor agonists should not be combined with DPP-4 inhibitors, Molecular Insights into the Potential

Additionally, other significant constituents comprise alkaloids, saponins, withanosides, and sitoindosides, which manifest antioxidant, anti-inflammatory, and anxiolytic properties (76)

However, its best to consult a healthcare provider before starting, especially if: Youre pregnant or breastfeeding Youre on long-term medication You have known liver or kidney conditions As always, taking supplements responsibly ensures long-term gains without complications

This suggests that sulforaphane could not only be a potential drug candidate but also be used in combination with current anti-cancer treatments

participated in the design and coordination of the study